All sponsors

GC Biopharma Corp

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS7
PHASE 3 / 2-34
RECRUITING4
READOUTS ≤12 MONTHS2
READOUT SLIPPED >6 MO40%

Delay Index: of 5 active trials registered more than a year ago, 2 have moved their primary completion (readout) date by more than 6 months since first registration (median +0.0 months). See all sponsors →

Open GC Biopharma Corp on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
GC5107
NCT04565015
P3Active, not recruitingPrimary Immune Deficiency242026-05 (+36 mo)
GC3111B
NCT06997627
P1/2RecruitingTetanus-diphtheria-acellular Pertussis (Tdap)1202026-05
Undiluted I.V.-Hepabig inj(GC5103)
NCT05686759
P3RecruitingHepatitis B1052026-06-30 (+19 mo)
MG1111 (Barycela inj.)
NCT07054099
P3RecruitingVaricella (Chickenpox); Chickenpox Vaccine4742027-08
GC4006A
NCT07936188
P2Enrolling by invitationCovid-19 Prevention2102027-10
GC3114B
NCT07883928
P2/3Not yet recruitingInfluenza A, Influenza B; Influenza Vaccination18062028-03
HM15421/GC1134A
NCT06858397
P1/2RecruitingFabry Disesase182028-08-30